Aclaris Announces Proposed Public Offering of Common Stock
WAYNE, PA — Aclaris Therapeutics, Inc. (Nasdaq: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, this week announced that it intends to offer and …
Aclaris Announces Proposed Public Offering of Common Stock Read More